QA: Mirati Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2023_Mirati_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc.

  xvar xval
0 AssetsCurrent 1,108,961,000
1 IntangibleAssetsNetIncludingGoodwill 14,914,000
2 PropertyPlantAndEquipmentNet 17,540,000
3 remainder_Assets 61,232,000
4 LiabilitiesCurrent 159,448,000
5 LiabilitiesNoncurrent 46,683,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 239,798,000
9 ResearchAndDevelopmentExpense 531,627,000
10 remainder_Expenses 1,108,000
11 remainder_Revenues 12,436,000
12 remainder_NetIncome 19,230,000
13 remainder_ComprehensiveNetIncome -12,787,000
  yvar yval
0 Assets 1,202,647,000
1 Liabilities 206,131,000
2 Expenses 772,533,000
3 Revenues 12,436,000
4 StockholdersEquity 996,516,000
5 NetIncome -740,867,000
6 ComprehensiveNetIncome -747,260,500
7 BaseVar 1,112,882,000
8 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time